SEC Form 4 · accession 0001209191-16-089804
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John F Crowley
Officer — Chairman & CEO · Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $11.74 | Jan 4, 2016 | A | 250,000 | A | — | Jan 4, 2026 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 4, 2017. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2017, with the final installment vesting on January 1, 2020.